共 50 条
- [42] Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (04): : 265 - 271
- [43] Once-daily radiotherapy to ≥59.4 Gy versus twice-daily radiotherapy to ≥45.0 Gy with concurrent chemotherapy for limited-stage small-cell lung cancer: a comparative analysis of toxicities and outcomes Japanese Journal of Radiology, 2010, 28 : 340 - 348
- [44] Phase I study of hypofractionated dose-escalated thoracic radiotherapy for limited-stage small-cell lung cancer INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 65 (02): : 466 - 473
- [45] A Strategy to Reduce Acute Toxicity from Twice Daily Chemoradiation Therapy for Limited-Stage Small-Cell Lung Cancer INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E503 - E503
- [47] Left Upper Lobectomy vs Trisegmentectomy for Lung Cancer: A Propensity Score-Matched Comparison ANNALS OF THORACIC SURGERY, 2025, 119 (04): : 786 - 795
- [48] The diagnosis of limited stage small-cell lung cancer WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2008, 12 (01): : 1 - 5
- [49] Facility-Level Analysis of Twice Daily Radiation Utilization for Limited Stage Small Cell Lung Cancer INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : E67 - E67
- [50] Which fractionation of radiotherapy is best for limited-stage small-cell lung cancer? LANCET ONCOLOGY, 2017, 18 (08): : 994 - 995